Horizontal gaze palsy with progressive scoliosis can result from compound heterozygous mutations in ROBO3

Journal of Medical Genetics (Impact Factor: 6.34). 04/2006; 43(3):e11. DOI: 10.1136/jmg.2005.035436
Source: PubMed


Horizontal gaze palsy with progressive scoliosis (HGPPS) is an autosomal recessive disorder characterised by congenital absence of horizontal gaze, progressive scoliosis, and failure of the corticospinal and somatosensory axon tracts to decussate in the medulla. We previously reported that HGPPS patients from consanguineous pedigrees harbour homozygous mutations in the axon guidance molecule ROBO3.
We now report two sporadic HGPPS children of non-consanguineous parents who harbour compound heterozygous mutations in ROBO3. The mother of one of the children also had scoliosis DNA was extracted from a blood sample from each participant using a standard protocol, and the coding exons of ROBO3 were amplified and sequenced as previously described.
Each patient harboured two unique heterozygous mutations in ROBO3, having inherited one mutation from each parent.
HGPPS can result from compound heterozygous mutations. More comprehensive examinations of parents and siblings of HGPPS patients are required to determine if the incidence of scoliosis in individuals harbouring heterozygous ROBO3 mutations is greater than in the general population.

Download full-text


Available from: Elias Traboulsi, Feb 09, 2014
  • Source
    • "Phenotypic variability appears to be quite common in genomic syndromes, and a variety of hypotheses, ranging from a two hit model [9], to occult compound heterozygous mutations within deleted regions [10] "
    [Show abstract] [Hide abstract]
    ABSTRACT: Potocki-Lupski syndrome (PTLS; OMIM 610883) is a genomic syndrome that arises as a result of a duplication of 17p11.2. Although numerous cases of individuals with PTLS have been presented in the literature, its behavioral characterization is still ambiguous. We present a male child with a de novo dup(17)(p11.2p11.2) and he does not possess any autistic features, but is characterized by severe speech and language impairment. In the context of the analyses of this patient and other cases of PTLS, we argue that the central feature of the syndrome appears to be related to diminished speech and language capacity, rather than the specific social deficits central to autism.
    Brain & development 12/2011; 34(8):700-3. DOI:10.1016/j.braindev.2011.11.003 · 1.88 Impact Factor
  • Source
    • "One patient displayed bilateral synergistic convergence without pupil constriction upon attempting to gaze horizontally to one side or the other [5]. Vertical eye movements are mainly unaffected [2,7]. Nystagmus presents in many patients and is mostly horizontal and pendular, with low amplitude [2,3,8]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Clinical and molecular characterization of patients with horizontal gaze palsy with progressive scoliosis (HGPPS) to extend existing knowledge of the phenotype caused by mutations in the Roundabout homolog of Drosophila 3 (ROBO3) gene. Four patients (aged 6 months to 13 years), two of them siblings, with features of horizontal gaze palsy and their parents were examined clinically and by molecular testing of the ROBO3 gene. The three families were unrelated, but parents in each family were consanguineous. We identified three novel homozygous ROBO3 mutations in four patients with typical ophthalmologic signs of HGPPS. We found an exonic insertion/deletion mutation (c.913delAinsTGC; p.Ile305CysfsX13), a 31 bp deletion including the donor splice site of exon 17 and adjacent exonic and intronic sequences (c.2769_2779del11, 2779+1_+20del20), and a missense mutation located next to a splice donor site (c.3319A>C) resulting in skipping of exon 22, as shown by cDNA analysis. We describe three novel mutations in the ROBO3 gene and the detailed clinical phenotype of HGPPS. One patient displayed marked convergence upon attempting smooth pursuits to both sides. In one patient, the typical ophthalmologic phenotype, the neuroradiologic findings, and molecular testing led to the diagnosis even before scoliosis developed. In addition to the typical magnetic resonance imaging brain signs of HGPPS, this patient had marked hypoplasia of the frontal lobes and corpus callosum. In summary, diagnosis of HGPPS may be established by ophthalmologic and molecular investigation early in life, allowing ongoing orthopedic surveillance from an early stage.
    Molecular vision 07/2011; 17:1978-86. · 1.99 Impact Factor
  • Source
    • "This pattern is nicely illustrated by homozygous or compound heterozygous mutations in the ROBO3 gene (encoding the axon guidance receptor ROBO3/Rig-1), which cause the disorder horizontal gaze palsy with progressive scoliosis (HGPPS) (Chan et al., 2006; Jen et al., 2004). HGPPS is characterized by absent horizontal gaze from birth (an inability to move the eyes to the left or right) followed by development of scoliosis, or curvature of the spine, within the first decade of life. "
    [Show abstract] [Hide abstract]
    ABSTRACT: One of the biggest challenges in neuroscience is illuminating the architecture of developmental brain disorders, which include structural malformations of the brain and nerves, intellectual disability, epilepsy, and some psychiatric conditions like autism and potentially schizophrenia. Ongoing gene identification reveals a great diversity of genetic causes underlying abnormal brain development, illuminating new biochemical pathways often not suspected based on genetic studies in other organisms. Our greater understanding of genetic disease also shows the complexity of allelic diversity, in which distinct mutations in a given gene can cause a wide range of distinct diseases or other phenotypes. These diverse alleles not only provide a platform for discovery of critical protein-protein interactions in a genetic fashion, but also illuminate the likely genetic architecture of as yet poorly characterized neurological disorders.
    Neuron 10/2010; 68(2):245-53. DOI:10.1016/j.neuron.2010.09.042 · 15.05 Impact Factor
Show more